Beyond Air prices $5.51 Series A and Series B warrants in $30.1 million private placement

• Beyond Air priced a private placement with Series A and Series B common stock purchase warrants covering up to 3,611,692 shares.
• Warrants carry a USD 5.51 exercise price; Series A expires in one year or 45 days after FDA approval of LungFit II.
• Series B warrants expire five years from issuance; gross proceeds could reach USD 30.1 million if all warrants are exercised for cash.
• Beyond Air also issued pre-funded warrants for up to 1,638,835 shares; combined price set at USD 5.66 per share equivalent.
• Company must file a resale registration statement within 15 days of closing; seeks effectiveness within 75 days if SEC conducts a full review.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607300700PRIMZONEFULLFEED9800811) on July 30, 2026, and is solely responsible for the information contained therein.